|
|
Blood, 15 May 2007, Vol. 109, No. 10, pp. 4343-4350.
Prepublished online as a Blood First Edition Paper on January 18, 2007; DOI 10.1182/blood-2006-05-025940.
 Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
GATA3 up-regulation associated with surface expression of CD294/CRTH2: a unique feature of human Th cells
Umberto De Fanis1,
Francesca Mori1,
Rebecca J. Kurnat1,
Won Kyung Lee1,
Maria Bova1,
N. Franklin Adkinson1, and
Vincenzo Casolaro1
1 Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD
GATA-3 and T-box expressed in T cells (T-bet) play central roles in Th-cell development and function. Consistently, studies in mice document their selective expression in Th1 and Th2 cells, respectively. In contrast, it is not clear whether these genes are regulated in human Th cells. Here we show that T-bet expression is polarized to a comparable degree in human and mouse Th-cell cultures, while only mouse GATA3 is subject to substantial regulation. This did not reflect differential skewing efficiency in human versus mouse cultures, as these contained similar frequencies of IFN- – and IL-4–producing cells. However, GATA-3 was expressed at significantly higher levels in human IL-4–producing cells enriched via capture with monoclonal antibodies (mAbs) against the PGD2 receptor, CRTH2, the best selective Th2-cell surface marker to date. Along with increased IL-4 and GATA-3, CRTH2+ Th cells isolated from Th2-skewed cultures or the circulating memory pool exhibited markedly decreased IFN- and T-bet expression. Thus, the human GATA-3 gene is not regulated in response to polarizing signals that are sufficient to direct Th2-specific expression in mouse cells. This postulates the involvement of an additional level of complexity in the regulation of human GATA-3 expression and stresses the existence of nontrivial differences in the regulation of human versus mouse T-cell function.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
R. G. Jenner, M. J. Townsend, I. Jackson, K. Sun, R. D. Bouwman, R. A. Young, L. H. Glimcher, and G. M. Lord
The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes
PNAS,
October 20, 2009;
106(42):
17876 - 17881.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ravoet, C. Sibille, C. Gu, M. Libin, B. Haibe-Kains, C. Sotiriou, M. Goldman, F. Roufosse, and K. Willard-Gallo
Molecular profiling of CD3-CD4+ T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways
Blood,
October 1, 2009;
114(14):
2969 - 2983.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Hashimoto-Okada, T. Kitawaki, N. Kadowaki, S. Iwata, C. Morimoto, T. Hori, and T. Uchiyama
The CD70-CD27 interaction during the stimulation with dendritic cells promotes naive CD4+ T cells to develop into T cells producing a broad array of immunostimulatory cytokines in humans
Int. Immunol.,
August 1, 2009;
21(8):
891 - 904.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Tahvanainen, T. Kallonen, H. Lahteenmaki, K. M. Heiskanen, J. Westermarck, K. V. S. Rao, and R. Lahesmaa
PRELI is a mitochondrial regulator of human primary T-helper cell apoptosis, STAT6, and Th2-cell differentiation
Blood,
February 5, 2009;
113(6):
1268 - 1277.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
